The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet’s Disease

Table 1

Demographic and laboratory values of patients included in this study.

Variable	Behçet’s disease	Control	p value
Number of patients	30	25
Age, years	40.29 ± 11.50	37 ± 5.66	0.179
Gender (M/F)	16/19	14/11	0.441
Hb, g/dL	13.71 ± 1.66	14.58 ± 1.43	0.065
MCV, fL	84.54 ± 5.60	87.22 ± 4.18	0.041
WBC, (mm^3)	7120 ± 1895	6816 ± 1578	0.589
Platelets, 10^3 mm^3	228 (116–532)	224 (144–361)	0.509
ALT, U/L	19 (8–132)	16 (10–40)	0.221
AST, U/L	20 (11–91)	18 (10–41)	0.223
ALP, U/L	73 (17–159)	63 (45–102)	0.052
GGT, U/L	22 (4–100)	15 (10–37)	0.105
ESR, mm/hour	15 (2–64)	6 (2–12)	<0.001
CRP, mg/dL	0.69 (0.01–10.9)	0.04 (0.01–0.20)	0.235
Fecal calprotectin μg/g	48 (33–770)	18 (8–30)	<0.001

Non-normally distributed parameters with “” sign were expressed as median (minimum–maximum).
WBC: white blood cell, Hb: hemoglobin, MCV: mean corpuscular volume, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, GGT: gamma-glutamyl transferase, ESR: erythrocyte sedimentation rate, and CRP: C-reactive protein.